| ||||||||||||||
|
|
|||||||||||||


*Department of Critical Care Medicine, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada;
Department of Neonatology, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia; and
Division of Neonatology, Royal Womens Hospital, University of Melbourne, Melbourne, Australia
Address correspondence and reprint requests to Jennifer Sokol, FRACP, FJFICM, Department of Neonatal Intensive Care, Princess Margaret Hospital for Children, Roberts Road, Subiaco, 6008 Western Australia, Australia. Address e-mail to jenni.sokol{at}health.wa.gov.au
We systematically reviewed randomized controlled trials examining inhaled nitric oxide (INO) for the treatment of acute respiratory distress syndrome or acute lung injury in children and adults. Qualitative assessments of identified trials were made, and metaanalyses were performed according to Cochrane methodology. Five randomized controlled trials (n = 535) met entry criteria. One study demonstrated significant improvement in oxygenation in the first 4 days of treatment, with no difference after this. There was no difference in ventilator-free days between treatment and placebo groups, and no specific dose of INO was more advantageous than any other. INO had no effect on mortality in trials without crossover of treatment failures to open-label INO (relative risk, 0.98; 95% confidence interval, 0.661.44). Other clinical indicators of effectiveness, such as duration of hospital and intensive care stay, were inconsistently reported. Lack of data prevented assessment of all outcomes. If further trials assessing INO in acute respiratory distress syndrome or acute lung injury are to proceed, they should be stratified for primary etiology, incorporate other modalities that may affect outcome, and evaluate clinically relevant outcomes before any benefit of INO can be excluded.
This article has been cited by other articles:
![]() |
N. K J Adhikari, K. E A Burns, J. O Friedrich, J. T Granton, D. J Cook, and M. O Meade Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis BMJ, April 14, 2007; 334(7597): 779 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takenaka, Y. Nishimura, T. Nishiuma, A. Sakashita, T. Yamashita, K. Kobayashi, M. Satouchi, T. Ishida, S. Kawashima, and M. Yokoyama Ventilator-induced lung injury is reduced in transgenic mice that overexpress endothelial nitric oxide synthase Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1078 - L1086. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J.D. Griffiths and T. W. Evans Inhaled Nitric Oxide Therapy in Adults N. Engl. J. Med., December 22, 2005; 353(25): 2683 - 2695. [Full Text] [PDF] |
||||
![]() |
E. Fan, D. M. Needham, and T. E. Stewart Ventilatory Management of Acute Lung Injury and Acute Respiratory Distress Syndrome JAMA, December 14, 2005; 294(22): 2889 - 2896. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hauser, H. Bracht, M. Matejovic, P. Radermacher, and B. Venkatesh Nitric Oxide Synthase Inhibition in Sepsis? Lessons Learned from Large-Animal Studies Anesth. Analg., August 1, 2005; 101(2): 488 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Grichnik and T. A. D'Amico Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 317 - 334. [Abstract] [PDF] |
||||
![]() |
R. W. Taylor, J. L. Zimmerman, R. P. Dellinger, R. C. Straube, G. J. Criner, K. Davis Jr, K. M. Kelly, T. C. Smith, and R. J. Small Low-Dose Inhaled Nitric Oxide in Patients With Acute Lung Injury: A Randomized Controlled Trial JAMA, April 7, 2004; 291(13): 1603 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Adhikari and J. T. Granton Inhaled Nitric Oxide for Acute Lung Injury: No Place for NO? JAMA, April 7, 2004; 291(13): 1629 - 1631. [Full Text] [PDF] |
||||
|